Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
GlobeNewswire
· Poster outlines the parameters for developing a flow-cytometry-based PPMP as a companion diagnostic to predict volasertib..